Darvon & Darvocet Pose Heart Risks

The U.S. Federal Drug Administration is requesting all manufacturers of the opioid pain reliever propoxyphene (Darvon and Darvocet) to withdraw them from the market due to a high risk of abnormal electrical activity in the heart--even when taken at therapeutic doses. PositiveTip: Current users should discontinue these products and consult with their healthcare provider.

Read MoreLong right arrow